MedPath

Physical Activity Experiment on Male Prostate Cancer Patients

Not Applicable
Completed
Conditions
Cancer Prostate
Registration Number
NCT03866785
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

Prostate cancer is the most common cancer in France (56,841 cases in 2012). Although the benefits of physical activity (PA) in cancer patients are currently well established in the scientific literature, several studies have shown that this population is not sufficiently active. Strengthen patient adherence to prevention counseling by the physical activity (PA) is emerging as a new challenge for personalized treatment in oncology. In order to encourage the engagement and maintenance in a regular PA of cancer patients, first, their experiences of physical activity (PA) practice should be considered and their initial social representations of the practice considered. Secondarily, it is also important to identify health professionals who retain a key role in defining the framework, objectives and means of action to promote lifestyle changes towards a more active lifestyle. In addition, peer mentoring appears to offer promising perspectives for promoting adherence and long-term maintenance in physical activity (PA) of cancer patients.

Detailed Description

The main objective of this project is to measure the adherence of prostate cancer patients to a physical activity program with a tracking of the motivation by a pair.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
66
Inclusion Criteria

Not provided

Exclusion Criteria

For step 1= In the course of cancer treatment (excluding hormonal therapy)

For step 2= Patient in sedentary lifestyle

For step 3=

  • In the course of cancer treatment (excluding hormonal therapy)
  • Cardiac or respiratory conditions contraindicating physical activity

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Physical Activity sessions performedAt month 3

Analysis of the proportion (%) of Physical Activity sessions performed after 3 months of intervention.

Secondary Outcome Measures
NameTimeMethod
sedentary lifestyle via activity actigraphAt month 3

Assessment of sedentary lifestyle via activity actigraph

physical activity via activity actigraphAt month 3

Assessment of physical activity via activity actigraph

Patient's activationAt month 3

Measure patient's activation via questionnaire Patient Activation Measure (PAM).

brakes blocking interventionAt month 3

Identification of brakes blocking intervention via interviews and Adult Physical Activity Questionnaire (APAQ). APAQ measures the sleeping time (h/night), sedentary time (h/week) and physical activity time (h/day)

levers favoring interventionAt month 3

Identification of levers favoring intervention via interviews and Adult Physical Activity Questionnaire (APAQ). APAQ measures the sleeping time (h/night), sedentary time (h/week) and physical activity time (h/day)

Peers mobilizedAt month 3

Number of peers mobilized

Trial Locations

Locations (3)

ICLN - département de radiothérapie

🇫🇷

Saint-Priest-en-Jarez, France

ICLN - Oncologie médicale

🇫🇷

Saint-Priest-en-Jarez, France

CHU Saint-Etienne

🇫🇷

Saint-Étienne, France

ICLN - département de radiothérapie
🇫🇷Saint-Priest-en-Jarez, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.